MRE11 and ATM Expression Levels Predict Rectal Cancer Survival and Their Association with Radiotherapy Response

Upregulated Polo-Like Kinase 1 Expression Correlates with Inferior Survival Outcomes in Rectal Cancer

(2015) T. G. Tut et al.   PLoS One

MRE11-Deficiency Associated with Improved Long-Term Disease Free Survival and Overall Survival in a Subset of Stage III Colon Cancer Patients in Randomized CALGB 89803 Trial

(2014) Thomas Pavelitz et al.   PLoS One

Neoadjuvant Radiotherapy for Rectal Cancer: Meta-analysis of Randomized Controlled Trials

(2013) Nuh N. Rahbari et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic Significance of Partial Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer

(2013) Yen-Chien Lee et al.   DISEASES OF THE COLON & RECTUM

Differences in Survival between Colon and Rectal Cancer from SEER Data

(2013) Yen-Chien Lee et al.   PLoS One

Treatment of locally advanced rectal cancer: Controversies and questions

(2012) Atthaphorn Trakarnsanga   WORLD JOURNAL OF GASTROENTEROLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

Sampling Strategies for Tissue Microarrays to Evaluate Biomarkers in Ovarian Cancer

(2009) J. Permuth-Wey et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION